A lifestyle program of exercise and weight loss is effective in preventing and treating type 2 diabetes mellitus: Why are programs not more available?

Preventive Medicine

Volumn 80, Issue , 2015, Pages 50-52

  Ades, Philip A ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Exercise training; Prevention; Treatment; Type 2 diabetes mellitus; Weight loss

Indexed keywords

HEMOGLOBIN A1C; METFORMIN;

BLOOD GLUCOSE MONITORING; EVIDENCE BASED PRACTICE; EXERCISE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEALTH PROGRAM; HEART REHABILITATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; TREATMENT DURATION; WEIGHT REDUCTION; DIABETES MELLITUS, TYPE 2; HEALTH BEHAVIOR; HEALTH PROMOTION; LIFESTYLE; OBESITY; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; EXERCISE; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; LIFE STYLE; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 84942553377     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2015.03.014     Document Type: Note

References (21)

1. Ades P.A. Cardiac rehabilitation and the secondary prevention of coronary heart disease. N. Engl. J. Med. 2001, 345:892-902.
2. Ades P.A., Pashkow F., Nestor J. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J. Cardpulm. Rehabil. 1997, 17:222-231.
3. Ades P.A., Savage P.D., Brawner C.A., Lyon C.E., Ehrman J.K., Bunn J.Y., Keteyian S.J. Aerobic capacity in patients entering cardiac rehabilitation. Circulation 2006, 113:2706-2712.
4. Ades P.A., Savage P.D., Toth M.J., Harvey-Berino J., Schneider D.L., Bunn J.Y., et al. High-caloric expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation 2009, 119:2671-2678.
5. Ades P.A., Savage P.D., Marney A.M., Harvey J., Evans K.A. Remission of recently diagnosed type 2 diabetes mellitus with weight loss and exercise. J. Cardpulm. Rehabil. Prev. 2015, (Jan 29. [Epub ahead of print]).
6. Balady G.J., Williams M.A., Ades P.A., Bittner V., Comoss P., Foody J., Franklin B.A., Sanderson B.K., Southard D. AHA/AACVPR core components of cardiac rehabilitation/secondary prevention programs. Circulation 2007, 115:2675-2682.
7. Bozack A., Millstein S., Garcel J.M., Kelly K., Ruberto R., Weiss L. Implementation and outcomes of the New York State YMCA diabetes prevention program: a multisite community-based translation, 2010-2012. Prev. Chron. Dis. 2014, 11:E115.
8. Buse J.B., Caprio S., Cefalu W.T., Ceriello A., Del Prato S., Inzucchi S.E., et al. How do we define cure of diabetes?. Diabetes Care 2009, 32:2133-2135.
9. Centers for Disease Control and Prevention National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014 2014, US Department of Health and Human Services, Atlanta, GA.
10. Curnier D., Savage P.D., Ades P.A. Geographic distribution of cardiac rehabilitation programs in the U.S. J. Cardpulm. Rehabil. 2005, 25:80-84.
11. Diabetes Prevention Program Research Group Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003, 26:2518-2523.
12. Geiss L.S., Wang J., Cheng Y.L., Thompson T.J., Barker L., Li Y., Albright A.L., Gregg E.W. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA 2014, 312:1218-1226.
13. Gregg E.W., Chen H., Wagenknecht L.E., Clark J.M., Delahanty L.M., Bantle J., et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012, 308:2489-2496.
14. Herman W.H., Hoerger T.J., Brandle M., Hicks K., Sorensen S., Zhang P., Hamman R.F., Ackermann R.T., Engelgau M.M., Ratner R.E. Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann. Intern. Med. 2005, 142:323-332.
15. http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?&NcaName=Intensive%20Behavioral%20Therapy%20for%20Obesity&bc=ACAAAAAAIAAA&NCAId=253&.
16. Kennedy A.G., MacLean C.D., Littenberg B., Ades P.A., Pinckney R.G. The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care 2005, 2:1029-1034.
17. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346:393-403.
18. Krukowski R.A., Pope R.A., Love S., Lensing S., Felix H.C., Prewitt T.E., West D. Examination of costs for a lay health educator-delivered translation of the Diabetes Prevention Program in senior centers. Prev. Med. 2013, 57:400-402.
19. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203.
20. Roglic G., Unwin N., Bennett P.H., Mathers C., Tuomilehto J., Nag S., Connolly V., King H. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005, 28:2130-2135.
21. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001, 344(18):1343-1350. (May 3).